Rebecca Taub
CIK 1423898 · Pres., R&D, and CMO · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$597.00M
Companies
2
Total Filings
43
Lifetime Open-Market Net
-$47.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Director | 1,108,207 | $538.71 | $597.00M | -$47.04M | 28 | 2026-06-18 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | SVP, Research & Development | 32,500 | — | — | $9.8K | 2 | 2008-12-19 |
Recent Filings · Page 2 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-12 | MDGL | Mixed | −5,455 | -$10.00M | EDGAR |
| 2025-12-10 | MDGL | Notice (144) | −18,650 | -$10.33M | EDGAR |
| 2025-08-13 | MDGL | Mixed | — | -$16.07M | EDGAR |
| 2025-08-12 | MDGL | Notice (144) | −43,263 | -$15.12M | EDGAR |
| 2025-08-11 | MDGL | Notice (144) | −3,200 | -$1.11M | EDGAR |
| 2025-07-22 | MDGL | Mixed | — | -$340.6K | EDGAR |
| 2025-07-18 | MDGL | Notice (144) | −1,000 | -$348.7K | EDGAR |
| 2025-07-18 | MDGL | Mixed | — | -$10.00M | EDGAR |
| 2025-07-17 | MDGL | Notice (144) | −2,657 | -$916.6K | EDGAR |
| 2025-07-16 | MDGL | Notice (144) | −26,444 | -$8.23M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.